Aquestive Therapeutics AQST -37.04% ▼ stock took a beating on Friday after the pharmaceutical company released an update on the regulatory approval of Anaphylm. This is the company’s epinephrine product designed to be taken orally. The interesting aspect is that the drug dissolves in the mouth, meaning no water or swallowing is required for its administration.
https://www.tipranks.com/news/why-is-aquestive-therapeutics-stock-aqst-down-today
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.